IL15 and central nervous system cancer: In murine GL261-luc gliomas an IL-15 superagonist complex (IL-15N72D:IL-15RαSu-Fc) as a single treatment or in combination with anti-PD-1 antibody, induced a robust anti-tumor immune response resulting in prolonged survival or tumor remission81.